← All stories
● Covered by 1 source · 1 reportLow impact1 negative

FDA Nominee Heidi Overton Dodges Questions on Trump's False Vaccine Claims

🔄 Updated 2h ago
New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • Heidi Overton is Trump's nominee for FDA Commissioner.
  • She contradicted Trump's false claims about the MMR vaccine.
  • Overton avoided directly stating if Trump could be wrong.
  • Concerns were raised about her objectivity and independence.

Senate Hearing for FDA Nominee

Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration (FDA), appeared before the Senate health committee for her confirmation hearing. Senators questioned her on various topics including vaccines, flavored vapes, birth control, and abortion. Overton, a physician with a doctoral degree in clinical investigation, currently serves as the deputy assistant to the president for domestic policy.

Contradicting Presidential Claims

During the hearing, Overton directly contradicted President Trump's past statements regarding the measles, mumps, and rubella (MMR) vaccine. Trump had previously falsely claimed the MMR vaccine was "quite lethal" and suggested splitting the vaccine into three separate immunizations without scientific basis. Overton affirmed that "the MMR vaccine is not lethal" and is "safe and effective."

Evasion on Presidential Fallibility

Despite contradicting Trump on vaccine safety, Overton repeatedly dodged questions from Senator Maggie Hassan (D-NH) about whether the President could ever be wrong. When pressed, Overton offered evasive responses, stating she had "robust discussions" with the President but not directly addressing the question of his potential fallibility. This evasion occurred even after she had stated the MMR vaccine was safe, directly countering Trump's earlier assertions.

Concerns Over Objectivity

Overton's past work at a conservative think tank and her clear stance opposing abortion have raised questions about her objectivity, particularly as the FDA is reviewing the safety of the abortion pill, mifepristone. Her reluctance to directly acknowledge the President's errors, even when contradicting his false claims, further fuels concerns about her independence in leading a scientific regulatory body like the FDA.

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~17 min · 13 stories · Sep 25

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

Reporting from

Heidi Overton, President Trump's nominee to lead the Food and Drug Administration, faced Senate committee questions regarding her stances on various health issues and her objectivity. Overton contradicted Trump's false claims about the MMR vaccine but repeatedly avoided answering whether the President could be wrong. This raises concerns about her independence and ability to lead a scientific agency impartially.